Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: AlzheimerDisease examines the drug discovery process for neurodegenerative diseases by focusing specifically on AlzheimerDisease and illustrating the paradigm necessary to ensure future research and treatment success.
The book explores diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of AlzheimerDisease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why these drugs tend to fail at the clinical stage, and examines AlzheimerDisease within the overall context of improving the drug discovery process for the treatment of other neurodegenerative disorders.
-Provides a compilation of chemical considerations required in drug discovery for the treatment of neurodegenerative disorders
-Examines different classes of compounds currently being used in discovery and development stages
-Explores in vitro and in vivo models with respect to their ability to translate these models to human conditions
-Distills the most significant information across multiple areas of Alzheimerdisease research to provide a single, comprehensive, and balanced resource